Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution
Filter News
Show All Results
News By Country
News By Tag
Conctract Remove
Related Tags


September 2014
Tu Mo Su Sa Fr Th We
2 1
August 2014
31 30 29 28 27

Conctract Press Releases

  + XML/RSS  



By Visiongain
A new report by visiongain, a London-based business information company, predicts sustained double-digit growth in the Chinese pharmaceutical market from 2011. National healthcare reforms will stimulate sales of drugs there.

By Visiongain
A new report by visiongain, a London-based business information company, predicts that world revenues for antibacterial drugs will reach $43.81bn in 2016.

By Visiongain
A new report by visiongain predicts that revenues for disease-modifying treatments for multiple sclerosis (MS) will rise to $15.8bn annually in 2015. That analysis appears in Multiple Sclerosis Treatment: World Drug Market 2012-2022.

By Visiongain
A new report by visiongain, a London-based business information provider, predicts that the global medical device contract manufacturing revenues will reach $95.7bn in 2021.

By Visiongain
A new report by Visiongain predicts the global advanced wound care market to be worth $14.6bn by 2021. The market generated $6.2bn in 2010, according to Advanced Wound Care: World Market Prospects 2011-2021, published in November 2011.

By Visiongain
A new report by visiongain, a London-based business information company, predicts that worldwide pharma contract sales revenues will reach $5.24bn in 2015. In particular, non-personal promotional services will stimulate market growth.

By Visiongain
Visiongain predicts that world revenues for rheumatoid arthritis drugs will rise strongly between 2011 and 2021. This market will grow to reach $17.3bn in 2015. The rheumatoid arthritis drugs market generated $12.7bn in 2010.

By Visiongain
A new report by visiongain predicts that the global companion diagnostics market will be worth $3.45bn by 2015. The market generated sales of $1.30bn in 2010, according to Companion Diagnostics: World Market Outlook 2011-2021, published in August.

By Visiongain
A new report by visiongain, a London-based business information company, predicts that global pharmacovigilance spending will be worth $15.46bn by 2015. The market was worth just under $12bn in 2010.



Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share